Innate Pharma (IPHA) Reports FY22, Provides Business Update

Go back to Innate Pharma (IPHA) Reports FY22, Provides Business Update
(NASDAQ: IPHA) Delayed: 1.79 --0 (-0%)
Previous Close $1.79    52 Week High
Open $1.79    52 Week Low
Day High $1.79    P/E N/A 
Day Low $1.79    EPS
Volume